Related Experiment Video

Updated: May 13, 2026

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid
08:49

Mapping the Cellular Distribution of an Optogenetic Protein Using a Light-Stimulation Grid

Published on: January 26, 2024

Targeting protein-protein interactions within the cyclic AMP signaling system as a therapeutic strategy for

Louisa C Y Lee1, Donald H Maurice, George S Baillie

  • 1Institute of Cardiovascular & Medical Science, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.

Future Medicinal Chemistry
|March 19, 2013
PubMed

Insights

Targeting cellular signaling requires precise protein-protein interactions. New peptides and small molecules disrupt these interactions, offering specific approaches to modulate cAMP signaling and avoid off-target effects in cardiac disease.

Area of Science:

  • Cellular biology
  • Molecular signaling
  • Cardiovascular research

Background:

  • The cyclic adenosine monophosphate (cAMP) signaling pathway regulates critical cellular functions.
  • Protein-protein interactions are essential for cAMP pathway fidelity and cellular localization.
  • Disregulation of cAMP signaling in the heart contributes to cardiac disease.

Purpose of the Study:

  • To review recent advances in targeting cAMP signaling pathways.
  • To discuss novel peptides and small molecules that disrupt specific protein-protein interactions.
  • To address the challenge of off-target effects associated with general cAMP inhibitors.

Main Methods:

  • Review of recent scientific literature on cAMP signaling.
  • Analysis of novel peptide and small molecule inhibitors.
  • Discussion of protein-protein interaction disruption strategies.

Main Results:

  • Identification of specific peptides and small molecules targeting cAMP pathway protein-protein interactions.
  • Demonstration of potential for targeted intervention in cAMP signaling.
  • Highlighting strategies to mitigate non-specific effects of traditional inhibitors.

Conclusions:

  • Targeting protein-protein interactions offers a precise method for modulating cAMP signaling.
  • Novel small molecules and peptides show promise for therapeutic applications in cardiac disease.
  • Specific disruption of interactions can overcome limitations of general pathway inhibitors.

More Related Videos

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy12:24

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy

Published on: September 29, 2016

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ06:03

Real-Time cAMP Dynamics in Live Cells Using the Fluorescent cAMP Difference Detector In Situ

Published on: March 22, 2024

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...